Eurohead Project: Migraine genes and neurobiological pathways

Familial basilar migraine associated with a new mutation in the ATP1A2 gene.

Ambrosini A, D'Onofrio M, Grieco GS, Di Mambro A, Montagna G, Fortini D, Nicoletti F, Nappi G, Sances G, Schoenen J, Buzzi MG, Santorelli FM, Pierelli F.

Neurology 2005;65:1826-8.

HLA-DRB1 genotyping in Italian migraine patients.

Rainero I, Dall'omo AM, Rubino E, Valfre W, Fasano ME, Rivoiro C, Brancatello F, Savi L, Gallone S, Pinessi L.

Neurosci Lett 2006;393:90-3.

Cough-Induced Hemiplegic Migraine with Impaired Consciousness in Cystic Fibrosis.

Rao DS, Infeld MD, Stern RC, Chelimsky TC.

Pediatr Pulmonol 2005;41:171-176

Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: Implications for the pathophysiology of migraine.

Levy D, Burstein R, Strassman AM.

Ann Neurol 2005;58:698-705

No evidence of ATP1A2 involvement in 12 multiplex Italian families with benign familial infantile seizures.

Martinelli Boneschi F, Aridon P, Zara F, Guerrini R, Marini C, De Fusco M, Comi G, Casari G.

Neurosci Lett 2005;388:71-4

Prevalence and size of directly detected patent foramen ovale in migraine with aura.

Schwerzmann M, Nedeltchev K, Lagger F, Mattle HP, Windecker S, Meier B, Seiler C.

Neurology 2005;65:1415-8.

Familial risks for migraine and other headaches among siblings based on hospitalizations in Sweden.

Hemminki K, Li X, Johansson SE, Sundquist K, Sundquist J.

Neurogenetics. 2005 Oct 19;:1-8 [Epub ahead of print]

Relationship of pain and symptoms to pubertal development in adolescents.

Leresche L, Mancl LA, Drangsholt MT, Saunders K, Korff MV.

Pain. 2005 Oct 4; [Epub ahead of print]

A genetic analysis of serotonergic biosynthetic and metabolic enzymes in migraine using a DNA pooling approach.

Johnson MP, Griffiths LR.

J Hum Genet. 2005 Oct 1; [Epub ahead of print]

Autopsy case of acute encephalopathy linked to familial hemiplegic migraine with cerebellar atrophy and mental retardation.

Takahashi T, Arai N, Shimamura M, Suzuki Y, Yamashita S, Iwamoto H, Inayama Y, Kameda Y, Kuroiwa Y.

Neuropathology 2005;25:228-34.

ATP1A2 mutations in 11 families with familial hemiplegic migraine.

Riant F, De Fusco M, Aridon P, Ducros A, Ploton C, Marchelli F, Maciazek J, Bousser MG, Casari G, Tournier-Lasserve E.

Hum Mutat 2005;26:281.

Genomewide significant linkage to migrainous headache on chromosome 5q21.

Nyholt DR, Morley KI, Ferreira MA, Medland SE, Boomsma DI, Heath AC, Merikangas KR, Montgomery GW, Martin NG.

Am J Hum Genet 2005;77:500-12

Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval.

Nappi RE, Sances G, Brundu B, De Taddei S, Sommacal A, Ghiotto N, Polatti F, Nappi G.

Hum Reprod 2005; 25 [Epub ahead of print]

Prognosis of migraine and tension-type headache: a population-based follow-up study.

Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R.

Neurology 2005; 65:580-5.

A positron emission tomographic study in spontaneous migraine.

Afridi SK, Giffin NJ, Kaube H, Friston KJ, Ward NS, Frackowiak RS, Goadsby PJ.

Arch Neurol 2005; 62:1270-5

Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches.

Moja P, Cusi C, Sterzi R, Canepari C.

Cochrane Database Syst Rev 2005;20:CD002919.

Parthenolide is the component of tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: studies in an animal model of migraine.

Tassorelli C, Greco R, Morazzoni P, Riva A, Sandrini G, Nappi G.

Cephalalgia 2005;25:612-621.

No evidence of ATP1A2 involvement in 12 multiplex Italian families with benign familial infantile seizures.

Boneschi FM, Aridon P, Zara F, Guerrini R, Marini C, De Fusco M, Comi G, Casari G.

Neurosci Lett 2005; Jul 15; [Epub ahead of print]

Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures.

Jen JC, Wan J, Palos TP, Howard BD, Baloh RW.

Neurology 2005; Jun 29; [Epub ahead of print]

Activation of the Transcription Factor NF-kappaB in the Nucleus Trigeminalis Caudalis in an Animal Model of Migraine.

Greco R, Tassorelli C, Cappelletti D, Sandrini G, Nappi G.

Neurotoxicology 2005; Jun 2; [Epub ahead of print]

Function and dysfunction of synaptic calcium channels: insights from mouse models.

Pietrobon D.

Curr Opin Neurobiol 2005; 15:257-65

Guidelines for Trials of Behavioral Treatments for Recurrent Headache, First Edition: American Headache Society Behavioral Clinical Trials Workgroup

Penzien DB, Andrasik F, Freidenberg BM, Houle TT, Lake AE, Lipchik GL, Holroyd KA, Lipton RB, McCrory DC, Nash JM, Nicholson RA, Powers SW, Rains JC, Wittrock DA

Headache 2005; 45 (suppl 2);S110-S132

Diffusion - and perfusion - weighted MR imaging in persistent migrainous visual disturbances.

Jager HR, Giffin NJ, Goadsby PJ.

Cephalalgia 2005;25:323-32.

The clinical characteristics of headache in patients with pituitary tumours.

Levy MJ, Matharu MS, Meeran K, Powell M, Goadsby PJ.

Brain. 2005 May 11; [Epub ahead of print]

Headache, cerebrovascular symptoms, and stroke. The Atherosclerosis Risk in Communities Study.

Stang PE, Carson AP, Rose KM, Mo J, Ephross SA, Shahar E, Szklo M.

Neurology. 2005 Apr 7; [Epub ahead of print]

FRAMIG 2000: medical and therapeutic management of migraine in France.

Lucas C, Chaffaut C, Artaz MA, Lanteri-Minet M.

Cephalalgia 2005;25:267-79

A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate.

Afridi SK, Matharu MS, Lee L, Kaube H, Friston KJ, Frackowiak RS, Goadsby PJ.

Brain 2005;128:932-9

Canadian Headache Society criteria for the diagnosis of acute migraine headache in the ED-do our patients meet these criteria?

Fiesseler FW, Riggs RL, Holubek W, Eskin B, Richman PB

Am J Emerg Med 2005;23:149-54

Specific kinetic alterations of human CaV2.1 calcium channels produced by mutation S218L causing familial hemiplegic migrane and delayed cerebral edema and coma after minor head trauma.

Tottene A, Pivotto F, Fellin T, Cesetti T, van den Maagdenberg AM, Pietrobon D

J Biol Chem 2005 Mar 2; [Epub ahead of print]

Psychiatric comorbidity in migraine: a review.

Radat F, Swendsen J

Cephalalgia 2005;25:165-78.

Cardiovascular risk factors and migraine: the GEM population-based study.

Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ.

Neurology 2005;64:614-20.

Patterns of specific antimigraine drug use - a study based on the records of 18 community pharmacies.

Lohman J, van der Kuy-de Ree M; the Group of Co-operating Pharmacists Sittard-Geleen and its environs.

Cephalalgia 2005;25:214-8.

Cluster headache prevalence in the Italian general population.

Torelli P, Beghi E, Manzoni GC.

Neurology 2005;64:469-74.

Sensitivity and specificity of the new international diagnostic criteria for migraine with aura.

Eriksen MK, Thomsen LL, Olesen J.

J Neurol Neurosurg Psychiatry 2005;76:212-7

Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies.

Etminan M, Takkouche B, Isorna FC, Samii A.

BMJ 2005;330:63

A New Susceptibility Locus for Migraine with Aura in the 15q11-q13 Genomic Region Containing Three GABA-A Receptor Genes.

Russo L, Mariotti P, Sangiorgi E, Giordano T, Ricci I, Lupi F, Chiera R, Guzzetta F, Neri G, Gurrieri F.

Am J Hum Genet 2005;76:327-33

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM for the BIBN 4096 BS Clinical Proof of Concept Study Group.

N Engl J Med 2004;350:1104-10.

Migraine as a risk factor for subclinical brain lesions.

Kruit MC, van Buchem MA, Hofman PAM, Bakkers JTN, Terwindt GM, Ferrari MD, Launer LJ.

JAMA 2004; 291:427-434

Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study.

Matharu MS, Levy MJ, Meeran K, Goadsby PJ

Ann Neurol 2004;56:488-94